Equity Research for the following companies: Lions Gate Entertainment (NYSE:LGF), Ariad (NASDAQ:ARIA), SAIC (NYSE:SAI), Patterson-UTI Energy (NASDAQ:PTEN), NovaGold (AMEX:NG), and Dendreon (NASDAQ:DNDN).

Equity Research for the following companies: Thompson Creek Metals (NYSE:TC), Ariad (NASDAQ:ARIA), ON Semiconductor (NASDAQ:ONNN), TriQuint (NASDAQ:TQNT), and Zagg (NASDAQ:ZAGG).

Equity Research for the following companies: CYS Investments (NYSE:CYS), Ariad Pharmaceuticals (NASDAQ:ARIA), Renren (NYSE:RENN), Symantec (NASDAQ:SYMC), Dell (NASDAQ:DELL) and Hartford Financial Services (NYSE:HIG).

Equity Research for the following companies: Ariad (NASDAQ:ARIA), Delta Air Lines (NYSE:DAL), BioSante (NASDAQ:BPAX), Bank of America (NYSE:BAC), Boston Scientific (NYSE:BSX) and News Corp (NASDAQ:NWSA).

MOUNTAIN VIEW, Calif., April 20, 2011 /PRNewswire/ -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the release of the iDimerize inducible dimerization systems. Based on the widely used ARGENT(TM) technology developed by ARIAD Pharmaceuticals, Inc.